2-[3-[(2S,5S,8S,11R,14S,17S,20S,27R)-27-[2-[[(6aR,9R,10aR)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]methylsulfanyl]ethylamino]-14-(4-aminobutyl)-5,20-dibenzyl-17-[(1R)-1-hydroxyethyl]-11-(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,28-octaoxo-8-(pyridin-4-ylmethyl)-1,4,7,10,13,16,19,22-octazacyclooctacos-2-yl]propyl]guanidine

C77H101N17O9S — CID 91809299

IUPAC2-[3-[(2S,5S,8S,11R,14S,17S,20S,27R)-27-[2-[[(6aR,9R,10aR)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]methylsulfanyl]ethylamino]-14-(4-aminobutyl)-5,20-dibenzyl-17-[(1R)-1-hydroxyethyl]-11-(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,28-octaoxo-8-(pyridin-4-ylmethyl)-1,4,7,10,13,16,19,22-octazacyclooctacos-2-yl]propyl]guanidine
SMILESC[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](NCCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O
InChIInChI=1S/C77H101N17O9S/c1-47(95)68-76(103)92-62(38-48-17-5-3-6-18-48)69(96)83-31-14-12-24-59(82-35-36-104-46-51-37-56-55-22-15-26-58-67(55)53(44-86-58)42-66(56)94(2)45-51)70(97)87-61(27-16-32-84-77(79)80)71(98)89-63(39-49-19-7-4-8-20-49)73(100)90-64(40-50-28-33-81-34-29-50)74(101)91-65(41-52-43-85-57-23-10-9-21-54(52)57)75(102)88-60(72(99)93-68)25-11-13-30-78/h3-10,15,17-23,26,28-29,33-34,43-44,47,51,56,59-66,68,82,85-86,95H,11-14,16,24-25,27,30-32,35-42,45-46,78H2,1-2H3,(H,83,96)(H,87,97)(H,88,102)(H,89,98)(H,90,100)(H,91,101)(H,92,103)(H,93,99)(H4,79,80,84)/t47-,51-,56-,59-,60+,61+,62+,63+,64+,65-,66-,68+/m1/s1
InChIKeyJMVMBUDRQOJPSQ-IOJSDMHCSA-N
MW1440.83 g/mol
LogP2.92
Rot. Bonds23

About 2-[3-[(2S,5S,8S,11R,14S,17S,20S,27R)-27-[2-[[(6aR,9R,10aR)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]methylsulfanyl]ethylamino]-14-(4-aminobutyl)-5,20-dibenzyl-17-[(1R)-1-hydroxyethyl]-11-(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,28-octaoxo-8-(pyridin-4-ylmethyl)-1,4,7,10,13,16,19,22-octazacyclooctacos-2-yl]propyl]guanidine

2-[3-[(2S,5S,8S,11R,14S,17S,20S,27R)-27-[2-[[(6aR,9R,10aR)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]methylsulfanyl]ethylamino]-14-(4-aminobutyl)-5,20-dibenzyl-17-[(1R)-1-hydroxyethyl]-11-(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,28-octaoxo-8-(pyridin-4-ylmethyl)-1,4,7,10,13,16,19,22-octazacyclooctacos-2-yl]propyl]guanidine (PubChem CID 91809299) has the molecular formula C77H101N17O9S and a molecular weight of 1440.83 g/mol. Its IUPAC name is 2-[3-[(2S,5S,8S,11R,14S,17S,20S,27R)-27-[2-[[(6aR,9R,10aR)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]methylsulfanyl]ethylamino]-14-(4-aminobutyl)-5,20-dibenzyl-17-[(1R)-1-hydroxyethyl]-11-(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,28-octaoxo-8-(pyridin-4-ylmethyl)-1,4,7,10,13,16,19,22-octazacyclooctacos-2-yl]propyl]guanidine.

Molecular Properties

Compound Name2-[3-[(2S,5S,8S,11R,14S,17S,20S,27R)-27-[2-[[(6aR,9R,10aR)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]methylsulfanyl]ethylamino]-14-(4-aminobutyl)-5,20-dibenzyl-17-[(1R)-1-hydroxyethyl]-11-(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,28-octaoxo-8-(pyridin-4-ylmethyl)-1,4,7,10,13,16,19,22-octazacyclooctacos-2-yl]propyl]guanidine
PubChem CID91809299
Molecular FormulaC77H101N17O9S
Molecular Weight1440.83 g/mol
Exact Mass1439.77
IUPAC Name2-[3-[(2S,5S,8S,11R,14S,17S,20S,27R)-27-[2-[[(6aR,9R,10aR)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]methylsulfanyl]ethylamino]-14-(4-aminobutyl)-5,20-dibenzyl-17-[(1R)-1-hydroxyethyl]-11-(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,28-octaoxo-8-(pyridin-4-ylmethyl)-1,4,7,10,13,16,19,22-octazacyclooctacos-2-yl]propyl]guanidine
SMILESC[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](NCCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O
InChIInChI=1S/C77H101N17O9S/c1-47(95)68-76(103)92-62(38-48-17-5-3-6-18-48)69(96)83-31-14-12-24-59(82-35-36-104-46-51-37-56-55-22-15-26-58-67(55)53(44-86-58)42-66(56)94(2)45-51)70(97)87-61(27-16-32-84-77(79)80)71(98)89-63(39-49-19-7-4-8-20-49)73(100)90-64(40-50-28-33-81-34-29-50)74(101)91-65(41-52-43-85-57-23-10-9-21-54(52)57)75(102)88-60(72(99)93-68)25-11-13-30-78/h3-10,15,17-23,26,28-29,33-34,43-44,47,51,56,59-66,68,82,85-86,95H,11-14,16,24-25,27,30-32,35-42,45-46,78H2,1-2H3,(H,83,96)(H,87,97)(H,88,102)(H,89,98)(H,90,100)(H,91,101)(H,92,103)(H,93,99)(H4,79,80,84)/t47-,51-,56-,59-,60+,61+,62+,63+,64+,65-,66-,68+/m1/s1
InChIKeyJMVMBUDRQOJPSQ-IOJSDMHCSA-N
XLogP2.92
TPSA403.19 Ų
H-Bond Donors15
H-Bond Acceptors15
Rotatable Bonds23
Heavy Atoms104
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001440.83
LogP ≤ 52.92
H-Bond Donors ≤ 515
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze 2-[3-[(2S,5S,8S,11R,14S,17S,20S,27R)-27-[2-[[(6aR,9R,10aR)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]methylsulfanyl]ethylamino]-14-(4-aminobutyl)-5,20-dibenzyl-17-[(1R)-1-hydroxyethyl]-11-(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,28-octaoxo-8-(pyridin-4-ylmethyl)-1,4,7,10,13,16,19,22-octazacyclooctacos-2-yl]propyl]guanidine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[3-[(2S,5S,8S,11R,14S,17S,20S,27R)-27-[2-[[(6aR,9R,10aR)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]methylsulfanyl]ethylamino]-14-(4-aminobutyl)-5,20-dibenzyl-17-[(1R)-1-hydroxyethyl]-11-(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,28-octaoxo-8-(pyridin-4-ylmethyl)-1,4,7,10,13,16,19,22-octazacyclooctacos-2-yl]propyl]guanidine?
The IUPAC name of 2-[3-[(2S,5S,8S,11R,14S,17S,20S,27R)-27-[2-[[(6aR,9R,10aR)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]methylsulfanyl]ethylamino]-14-(4-aminobutyl)-5,20-dibenzyl-17-[(1R)-1-hydroxyethyl]-11-(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,28-octaoxo-8-(pyridin-4-ylmethyl)-1,4,7,10,13,16,19,22-octazacyclooctacos-2-yl]propyl]guanidine (CID 91809299) is 2-[3-[(2S,5S,8S,11R,14S,17S,20S,27R)-27-[2-[[(6aR,9R,10aR)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]methylsulfanyl]ethylamino]-14-(4-aminobutyl)-5,20-dibenzyl-17-[(1R)-1-hydroxyethyl]-11-(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,28-octaoxo-8-(pyridin-4-ylmethyl)-1,4,7,10,13,16,19,22-octazacyclooctacos-2-yl]propyl]guanidine.
What is the SMILES notation for 2-[3-[(2S,5S,8S,11R,14S,17S,20S,27R)-27-[2-[[(6aR,9R,10aR)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]methylsulfanyl]ethylamino]-14-(4-aminobutyl)-5,20-dibenzyl-17-[(1R)-1-hydroxyethyl]-11-(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,28-octaoxo-8-(pyridin-4-ylmethyl)-1,4,7,10,13,16,19,22-octazacyclooctacos-2-yl]propyl]guanidine?
The canonical SMILES for 2-[3-[(2S,5S,8S,11R,14S,17S,20S,27R)-27-[2-[[(6aR,9R,10aR)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]methylsulfanyl]ethylamino]-14-(4-aminobutyl)-5,20-dibenzyl-17-[(1R)-1-hydroxyethyl]-11-(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,28-octaoxo-8-(pyridin-4-ylmethyl)-1,4,7,10,13,16,19,22-octazacyclooctacos-2-yl]propyl]guanidine is C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](NCCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O.
What is the InChIKey of 2-[3-[(2S,5S,8S,11R,14S,17S,20S,27R)-27-[2-[[(6aR,9R,10aR)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]methylsulfanyl]ethylamino]-14-(4-aminobutyl)-5,20-dibenzyl-17-[(1R)-1-hydroxyethyl]-11-(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,28-octaoxo-8-(pyridin-4-ylmethyl)-1,4,7,10,13,16,19,22-octazacyclooctacos-2-yl]propyl]guanidine?
The InChIKey is JMVMBUDRQOJPSQ-IOJSDMHCSA-N. The full InChI is InChI=1S/C77H101N17O9S/c1-47(95)68-76(103)92-62(38-48-17-5-3-6-18-48)69(96)83-31-14-12-24-59(82-35-36-104-46-51-37-56-55-22-15-26-58-67(55)53(44-86-58)42-66(56)94(2)45-51)70(97)87-61(27-16-32-84-77(79)80)71(98)89-63(39-49-19-7-4-8-20-49)73(100)90-64(40-50-28-33-81-34-29-50)74(101)91-65(41-52-43-85-57-23-10-9-21-54(52)57)75(102)88-60(72(99)93-68)25-11-13-30-78/h3-10,15,17-23,26,28-29,33-34,43-44,47,51,56,59-66,68,82,85-86,95H,11-14,16,24-25,27,30-32,35-42,45-46,78H2,1-2H3,(H,83,96)(H,87,97)(H,88,102)(H,89,98)(H,90,100)(H,91,101)(H,92,103)(H,93,99)(H4,79,80,84)/t47-,51-,56-,59-,60+,61+,62+,63+,64+,65-,66-,68+/m1/s1.
What are the key properties of 2-[3-[(2S,5S,8S,11R,14S,17S,20S,27R)-27-[2-[[(6aR,9R,10aR)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]methylsulfanyl]ethylamino]-14-(4-aminobutyl)-5,20-dibenzyl-17-[(1R)-1-hydroxyethyl]-11-(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,28-octaoxo-8-(pyridin-4-ylmethyl)-1,4,7,10,13,16,19,22-octazacyclooctacos-2-yl]propyl]guanidine?
2-[3-[(2S,5S,8S,11R,14S,17S,20S,27R)-27-[2-[[(6aR,9R,10aR)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]methylsulfanyl]ethylamino]-14-(4-aminobutyl)-5,20-dibenzyl-17-[(1R)-1-hydroxyethyl]-11-(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,28-octaoxo-8-(pyridin-4-ylmethyl)-1,4,7,10,13,16,19,22-octazacyclooctacos-2-yl]propyl]guanidine has a molecular weight of 1440.83 g/mol, XLogP of 2.92, 23 rotatable bonds, 15 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-[(2S,5S,8S,11R,14S,17S,20S,27R)-27-[2-[[(6aR,9R,10aR)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]methylsulfanyl]ethylamino]-14-(4-aminobutyl)-5,20-dibenzyl-17-[(1R)-1-hydroxyethyl]-11-(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,28-octaoxo-8-(pyridin-4-ylmethyl)-1,4,7,10,13,16,19,22-octazacyclooctacos-2-yl]propyl]guanidine is sourced from PubChem (CID 91809299), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).